Ignite Creation Date:
2024-05-06 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05051722
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2021-09-11
Brief Title:
Leveraging Methylated DNA Markers MDMs in the Detection of Endometrial Cancer Ovarian Cancer and Cervical Cancer
Sponsor:
Organization:
Mayo Clinic
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
A sample of the vaginal fluid pool will be collected via a standard tampon from each study participant prior to any clinical exams or procedures
A peripheral blood sample will be collected from each study participant prior to any clinical exams or procedures
Enrollment Count:
2640
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 79180 |
Who Masked List: